bagremycin A: isolated from Streptomyces; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10422480 |
| CHEMBL ID | 4125959 |
| MeSH ID | M0406833 |
| Synonym |
|---|
| bagremycin a |
| (4-ethenylphenyl) 3-amino-4-hydroxybenzoate |
| CHEMBL4125959 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1491205 | Antimicrobial activity against Escherichia coli ATCC 25922 after 12 hrs by micro broth dilution method | |||
| AID1491204 | Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 12 hrs by micro broth dilution method | |||
| AID1491206 | Antimicrobial activity against Candida albicans after 12 hrs by micro broth dilution method | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.13) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||